{"id":"NCT01458951","sponsor":"Pfizer","briefTitle":"A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis","officialTitle":"A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2015-05","completion":"2015-06","firstPosted":"2011-10-25","resultsPosted":"2016-06-01","lastUpdate":"2016-06-01"},"enrollment":547,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis"],"interventions":[{"type":"DRUG","name":"tofacitinib","otherNames":["CP-690,550"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"tofacitinib 10 mg BID","type":"EXPERIMENTAL"},{"label":"Placebo BID","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or be intolerant to one of following treatments for ulcerative colitis: oral steroids, azathiopurine/6-mercaptopurine, or anti-TNF-alpha therapy.","primaryOutcome":{"measure":"Percentage of Participants With Remission at Week 8","timeFrame":"Week 8","effectByArm":[{"arm":"Tofacitinib 10 mg BID","deltaMin":16.6,"sd":null},{"arm":"Placebo BID","deltaMin":3.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0005"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":182,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","Colombia","Croatia","Czechia","Denmark","Estonia","France","Germany","Hungary","Israel","Latvia","Netherlands","New Zealand","Poland","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["38778549","38425446","37560161","37402275","36931693","36739367","36603566","36526796","36506749","36342120","36336750","36271912","36124702","35792493","35648151","35380740","35380664","34614208","34165201","34035832","33684552","33513294","33324993","33127596","32870265","32816215","32794567","32766762","31599001","31077827","30476584","30012431","29850873","29743836","29028981","28467869"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3921095&StudyName=A%20Study%20To%20Evaluate%20Both%20The%20Efficacy%20and%20Safety%20Profile%20of%20CP-690%2C550%20In%20Patients%20With%20Moderately%20to%20Severely%20Active%20Ulcerative%20Col"]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":429},"commonTop":["Headache","Arthralgia","Anaemia","Abdominal pain","Abdominal pain upper"]}}